ADAM(TS) |
a disintegrin and a metalloproteinase (with thrombospondin-1 motif) |
BM |
basement membrane |
CAF |
cancer-associated fibroblast |
CAM |
cell adhesion molecule |
CCN |
connective tissue growth factor (CTGF), cysteine-rich protein (Cyr61) and nephroblastoma overexpressed (NOV) |
EC |
endothelial cell |
ECM |
extracellular matrix |
ED-A/B |
extra domain-A/B |
EGF(R) |
epidermal growth factor (receptor) |
EMT |
epithelial–mesenchymal transition |
GAG |
glycosaminoglycan |
GPI |
glycosylphosphatidylinositol |
HGF |
hepatocyte growth factor |
HIF |
hypoxia-inducible factor |
H/LMW-HA |
high/low molecular weight hyaluronic acid |
LOXL |
lysyl oxidase-like |
LPA1R |
lysophosphatidic acid receptor 1 |
(MT-)MMP |
(membrane-type) matrix metalloproteinase |
NOX |
nicotinamide adenine dinucleotide phosphate (NADPH) oxidase |
PAR |
protease-activated receptor |
RHAMM |
receptor for hyaluronic acid-mediated migration |
ROS |
reactive oxygen species |
SIBLING |
small integrin-binding ligand N-linked glycoprotein |
SLRP |
small leucine-rich protein |
SPARC |
secreted protein acidic and rich in cysteine |
TC |
tumor cell |
TGF-β |
transforming growth factor- β |
TIMP |
tissue inhibitors of metalloproteinases |
TLR |
Toll-like receptor |
TME |
tumor microenvironment |
VEGF |
vascular endothelial cell growth factor |